Filed Pursuant to Rule 424(b)(5)
Registration File No. 333-209513
PROSPECTUS SUPPLEMENT
(To Prospectus dated April 12, 2016)
$76,250,000
7.25% Convertible Senior Notes due 2024
We are offering $76,250,000 aggregate principal amount of our 7.25% convertible senior notes due 2024 (the “notes”). The notes will bear interest at a rate of 7.25% per year, payable quarterly in arrears on January 15, April 15, July 15 and October 15 of each year, beginning on July 15, 2017. The notes will mature on April 30, 2024, unless earlier repurchased, redeemed or converted.
Holders may convert their notes at their option prior to April 30, 2023 only under the following circumstances:
•
during any calendar quarter after the calendar quarter ending June 30, 2017, if the closing sale price of our common stock for each of 20 or more trading days (whether or not consecutive) in a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter exceeds 130% of the conversion price in effect on the last trading day of the immediately preceding calendar quarter;
•
during the five consecutive business days immediately after any five consecutive trading day period in which the trading price per $25.00 principal amount of the notes for each trading day in that note measurement period was equal to or less than 97% of the conversion value of the notes on such trading day;
•
if we call any or all of the notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; and
•
if we make certain distributions on shares of our common stock or engage in certain specified corporate transactions.
In addition, the notes will be convertible irrespective of the foregoing circumstances from, and including, April 30, 2023 to, and including, the business day immediately preceding the maturity date. Upon conversion, we will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at our election, as described in this prospectus supplement.
The conversion rate will initially equal 1.6267 shares of our common stock per $25.00 principal amount of notes (equivalent to a conversion price of approximately $15.37 per share of our common stock). The conversion rate, and thus the conversion price, will be subject to adjustment as described in this prospectus supplement. Following the occurrence of a make-whole fundamental change or if we deliver a notice of redemption, we will, in certain circumstances, increase the conversion rate for a holder that converts its notes in connection with such make-whole fundamental change or notice of redemption, as the case may be.
We may not redeem the notes prior to April 30, 2022. We may redeem for cash all or any portion of the notes, at our option, on or after April 30, 2022 if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No “sinking fund” will be provided for the notes.
If we undergo a fundamental change, holders may require us to purchase the notes, in whole or in part, for cash at a fundamental change purchase price equal to 100% of the principal amount of the notes to be purchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change purchase date.
The notes will be our senior direct unsecured obligations and will not be guaranteed by any of our subsidiaries. The notes will rank equal in right of payment to any of our existing and future unsecured and unsubordinated indebtedness; effectively junior in right of payment to any of our existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all existing and future indebtedness, other liabilities (including trade payables) and (to the extent not held by us) preferred stock, if any, of our subsidiaries.
We have applied to list the notes on the New York Stock Exchange and expect trading of the notes to commence thereon within 30 days after the original issue date. The notes are expected to trade “flat.” This means that purchasers will not pay, and sellers will not receive, any accrued and unpaid interest on the notes that is not included in the trading price. Currently, there is no public market for the notes and it is not expected that a market for the notes will develop unless and until the notes are listed on the New York Stock Exchange. Our common stock is listed on the New York Stock Exchange under the ticker symbol “AJX.” On April 19, 2017, the last sale price of our common stock as reported on the New York Stock Exchange was $13.08 per share.
Investing in our notes involves certain risks. See “Risk Factors” beginning on page S-11 of this prospectus supplement and in the reports we file with the Securities and Exchange Commission (“SEC”) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), incorporated by reference in this prospectus supplement and the accompanying prospectus to read about factors you should consider before making an investment in our notes.
We elected to be taxed as a real estate investment trust for U.S. federal income tax purposes (“REIT”) beginning with our taxable year ended December 31, 2014. Our qualification as a REIT depends upon our ability to meet, on a continuing basis, various complex requirements under the Internal Revenue Code of 1986, as amended (the “Code”), relating to, among other things, the sources of our gross income, the composition and values of our assets, our distribution levels and the diversity of ownership of our capital stock. We believe that we are organized in conformity with the requirements for qualification as a REIT under the Code and that our current intended manner of operation enables us to meet the requirements for taxation as a REIT for U.S. federal income tax purposes. To assist us in qualifying as a REIT, among other purposes, ownership of our common stock by any person is generally limited to 9.8% of our outstanding common stock. In addition, our charter contains various other restrictions on the ownership and transfer of our common stock. See “Restrictions on Ownership and Transfer” beginning on page 17 of the accompanying prospectus.
We are an “emerging growth company” under the Jumpstart Our Business Startups Act (the “JOBS Act”) and are subject to reduced public company reporting requirements.
Neither the SEC nor any state securities commission has approved or disapproved of the notes or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
| | | Per Note | | | Total | |
Public offering price | | | | $ | 25.00 | | | | | $ | 76,250,000 | | |
Underwriting discounts and commissions(1) | | | | $ | 0.7525 | | | | | $ | 2,295,125 | | |
Proceeds, before expenses, to us | | | | $ | 24.2475 | | | | | $ | 73,954,875 | | |
(1)
The underwriting discounts and commissions payable amount reflects a reduced blended rate as a result of an institutional investor that is an existing stockholder purchasing approximately 13.9% of the principal amount of notes.
The underwriters will have the option to purchase, within a period of 30 days beginning on, and including, the date the notes are first issued, up to an additional $11,250,000 aggregate principal amount of notes from us at the public offering price less the underwriting discount. If the underwriters exercise this option in full, the total public offering price will be $87,500,000, the total underwriting discount and commissions paid by us will be $2,633,750, and total proceeds to the Company, before expenses, will be $84,866,250.
We expect that the notes will be ready for delivery in book-entry-only form through The Depository Trust Company on April 25, 2017.
Raymond James JMP Securities
The date of this prospectus supplement is April 20, 2017